Fla. Stat. 499.01211
Drug Wholesale Distributor Advisory Council

(1)

There is created the Drug Wholesale Distributor Advisory Council within the department. The council shall meet at least once each calendar quarter. Staff for the council shall be provided by the department. The council shall consist of 12 members who shall serve without compensation. The council shall elect a chairperson and a vice chairperson annually.

(2)

The Secretary of Business and Professional Regulation or his or her designee and the Secretary of Health Care Administration or her or his designee shall be members of the council. The Secretary of Business and Professional Regulation shall appoint 10 additional members to the council who shall be appointed to a term of 4 years each, as follows:Three persons, each of whom is employed by a different prescription drug wholesale distributor permitted under this part which operates nationally as defined in s. 499.003.One person employed by a prescription drug wholesale distributor permitted under this part as defined in s. 499.003.One person employed by a retail pharmacy chain located in this state.One person who is a member of the Board of Pharmacy and is a pharmacist licensed under chapter 465.One person who is a physician licensed pursuant to chapter 458 or chapter 459.One person who is an employee of a hospital licensed pursuant to chapter 395 and is a pharmacist licensed pursuant to chapter 465.One person who is an employee of a pharmaceutical manufacturer.One person who is an employee of a permitted medical gas manufacturer or medical gas wholesale distributor and who has been recommended by the Compressed Gas Association.

(a)

Three persons, each of whom is employed by a different prescription drug wholesale distributor permitted under this part which operates nationally as defined in s. 499.003.

(b)

One person employed by a prescription drug wholesale distributor permitted under this part as defined in s. 499.003.

(c)

One person employed by a retail pharmacy chain located in this state.

(d)

One person who is a member of the Board of Pharmacy and is a pharmacist licensed under chapter 465.

(e)

One person who is a physician licensed pursuant to chapter 458 or chapter 459.

(f)

One person who is an employee of a hospital licensed pursuant to chapter 395 and is a pharmacist licensed pursuant to chapter 465.

(g)

One person who is an employee of a pharmaceutical manufacturer.

(h)

One person who is an employee of a permitted medical gas manufacturer or medical gas wholesale distributor and who has been recommended by the Compressed Gas Association.

(3)

The council shall review this part and the rules adopted to administer this part annually, provide input to the department regarding all proposed rules to administer this part, make recommendations to the department to improve the protection of the prescription drugs and public health, make recommendations to improve coordination with other states’ regulatory agencies and the federal government concerning the wholesale distribution of drugs, and make recommendations to minimize the impact of regulation of the wholesale distribution industry while ensuring protection of the public health.

Source: Section 499.01211 — Drug Wholesale Distributor Advisory Council, https://www.­flsenate.­gov/Laws/Statutes/2024/0499.­01211 (accessed Aug. 7, 2025).

499.01
Permits 499.001
Florida Drug and Cosmetic Act 499.002
Purpose, administration, and enforcement of and exemption from this part 499.03
Possession of certain drugs without prescriptions unlawful 499.003
Definitions of terms used in this part 499.04
Fee authority 499.05
Rules 499.005
Prohibited acts 499.06
Embargoing, detaining, or destroying article or processing equipment which is in violation of law or rule 499.006
Adulterated drug or device 499.007
Misbranded drug or device 499.008
Adulterated cosmetics 499.009
Misbranded cosmetics 499.012
Permit application requirements 499.015
Registration of drugs and devices 499.023
New drugs 499.024
Drug product classification 499.025
Drug products in finished, solid, oral dosage form 499.026
Notification of manufacturer prescription drug price increases 499.028
Drug samples or complimentary drugs 499.029
Cancer Drug Donation Program 499.032
Phenylalanine 499.033
Ephedrine 499.035
Dimethyl sulfoxide (DMSO) 499.036
Restrictions on sale of dextromethorphan 499.039
Sale, distribution, or transfer of harmful chemical substances 499.041
Schedule of fees for drug, device, and cosmetic applications and permits, product registrations, and free-sale certificates 499.051
Inspections and investigations 499.0051
Criminal acts 499.052
Records of interstate shipment 499.0054
Advertising and labeling of drugs, devices, and cosmetics 499.055
Reports and dissemination of information by department 499.057
Expenses and salaries 499.062
Seizure and condemnation of drugs, devices, or cosmetics 499.065
Inspections 499.066
Penalties 499.067
Denial, suspension, or revocation of permit, certification, or registration 499.0121
Storage and handling of prescription drugs 499.0285
International Prescription Drug Importation Program 499.0295
Experimental treatments for terminal conditions 499.0661
Cease and desist orders 499.01201
Agency for Health Care Administration review and use of statute and rule violation or compliance data 499.01211
Drug Wholesale Distributor Advisory Council 499.02851
Federal arrangement to operate a pilot program for importing prescription drugs

Current through Fall 2025

§ 499.01211. Drug Wholesale Distributor Advisory Council's source at flsenate​.gov